{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:49:59Z","timestamp":1791352199813,"version":"4.3.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In patients receiving immune checkpoint inhibitors (ICIs), central nervous system (CNS) infections may mimic or coexist with neurological immune-related adverse events (irAEs). ICI-driven immune dysregulation has been proposed to amplify inflammation against latent pathogens (\u201cimmunotherapy infections due to dysregulated immunity\u201d, ITI-DI), but this remains a hypothesis-generating framework rather than a validated diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case Presentation<\/jats:title>\n                    <jats:p>\n                      A 54-year-old man with stage IIIC lung adenocarcinoma developed a herpes zoster eruption and lumbosacral pain 7 days after the first infusion of pembrolizumab-containing chemoimmunotherapy, followed by rapidly progressive flaccid paraplegia, urinary incontinence, and declining consciousness. Intravenous acyclovir was not initiated until 20 days after rash onset. The first cerebrospinal fluid (CSF) sample was xanthochromic and coagulated spontaneously in the collection tube (Froin-like CSF), precluding protein measurement. A second lumbar puncture showed mild pleocytosis (8 cells\/\n                      <jats:inline-formula>\n                        <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"m1\">\n                          <mml:mrow>\n                            <mml:mi>\u03bc<\/mml:mi>\n                          <\/mml:mrow>\n                        <\/mml:math>\n                      <\/jats:inline-formula>\n                      L; 70% neutrophils) and undetectable glucose; varicella-zoster virus (VZV) DNA was detected in CSF by post-mortem targeted polymerase chain reaction. Spinal Magnetic resonance imaging (MRI) showed diffuse meningeal enhancement; follow-up cranial imaging showed acute hydrocephalus. Despite intravenous acyclovir, corticosteroids, and intravenous immunoglobulin, the patient died 43 days after pembrolizumab initiation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case highlights VZV CNS infection as an important diagnostic consideration in ICI-treated patients who develop herpes zoster and neurological symptoms, because infection may mimic or coexist with a neurological irAE. The temporal relationship with pembrolizumab raises, but does not establish, the possibility that PD-1 blockade modified the inflammatory response. Prompt virological testing and adequately dosed antiviral therapy are central to management; the role of adjunctive immunomodulation remains uncertain and should be individualized.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1937378","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:51:23Z","timestamp":1791348683000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Fatal varicella-zoster virus meningoencephalitis with Froin-like cerebrospinal fluid and hydrocephalus following pembrolizumab-containing chemoimmunotherapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Fangfang","family":"Shen","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Shanxi Province Cancer Hospital\/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences\/Cancer Hospital Affiliated to Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Shanxi Province Cancer Hospital\/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences\/Cancer Hospital Affiliated to Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Shanxi Province Cancer Hospital\/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences\/Cancer Hospital Affiliated to Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/imr.13262","article-title":"Effects of immune-related adverse events (iraes) and their treatment on antitumor immune responses","volume":"318","author":"Blum","year":"2023","journal-title":"Immunol. Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2016.12.001","article-title":"Neurological adverse events associated with immune checkpoint inhibitors: review of the literature","volume":"73","author":"Cuzzubbo","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41571-020-0352-8","article-title":"Moving towards personalized treatments of immune-related adverse events","volume":"17","author":"Esfahani","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/ajco.13375","article-title":"Neurological immune-related adverse events associated with immune checkpoint inhibitors: a review of the literature","volume":"16","author":"Fan","year":"2020","journal-title":"Asia-Pacific J. Clin. Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1474-4422(09)70134-6","article-title":"Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment","volume":"8","author":"Gilden","year":"2009","journal-title":"Lancet Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/s41591-019-0523-2","article-title":"A case report of clonal EBV-like memory cd4+ t cell activation in fatal checkpoint inhibitor-induced encephalitis","volume":"25","author":"Johnson","year":"2019","journal-title":"Nat. Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1007650","DOI":"10.1371\/journal.ppat.1007650","article-title":"Varicella zoster virus productively infects human peripheral blood mononuclear cells to modulate expression of immunoinhibitory proteins and blocking PD-l1 enhances virus-specific CD8+ t cell effector function","volume":"15","author":"Jones","year":"2019","journal-title":"PLoS Pathogens"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.3390\/cancers16081499","article-title":"Reactivation of varicella-zoster virus in patients with lung cancer receiving immune checkpoint inhibitors: retrospective nationwide population-based cohort study from South Korea","volume":"16","author":"Jung","year":"2024","journal-title":"Cancers"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1447021","DOI":"10.3389\/fimmu.2024.1447021","article-title":"Toxicity in the era of immune checkpoint inhibitor therapy","volume":"15","author":"Keam","year":"2024","journal-title":"Front. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/s0022-510x(98)00171-3","article-title":"Profound cerebrospinal fluid pleocytosis and froin\u2019s syndrome secondary to widespread necrotizing vasculitis in an HIV-positive patient with varicella zoster virus encephalomyelitis","volume":"159","author":"Kleinschmidt-DeMasters","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.2217\/imt-2022-0152","article-title":"A case report of pulmonary nocardiosis during pembrolizumab: the emerging challenge of the infections on immunotherapy","volume":"14","author":"Lasagna","year":"2022","journal-title":"Immunotherapy"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1111\/1759-7714.13422","article-title":"Opportunistic infections complicating immunotherapy for non-small cell lung cancer","volume":"11","author":"Liu","year":"2020","journal-title":"Thorac. Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"104595","DOI":"10.1016\/j.critrevonc.2024.104595","article-title":"Central nervous system complications of immune checkpoint inhibitors: a comprehensive review","volume":"206","author":"Lopes","year":"2025","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1136\/thoraxjnl-2021-217260","article-title":"Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy","volume":"77","author":"Morelli","year":"2022","journal-title":"Thorax"},{"key":"B15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1473-3099(10)70026-8","article-title":"Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis","volume":"10","author":"M\u00fcller","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1212\/01.wnl.0000258549.13334.16","article-title":"The value of detecting anti-VZV igg antibody in CSF to diagnose VZV vasculopathy","volume":"68","author":"Nagel","year":"2007","journal-title":"Neurology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41572-020-0160-6","article-title":"Immune-related adverse events of checkpoint inhibitors","volume":"6","author":"Ramos-Casals","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2217\/imt-2017-0121","article-title":"Pembrolizumab as first-line therapy for metastatic non-small-cell lung cancer","volume":"10","author":"Reck","year":"2018","journal-title":"Immunotherapy"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","first-page":"11619","DOI":"10.3390\/ijms262311619","article-title":"Beyond tumor immunity: the disruption of endocrine and infectious homeostasis by immune checkpoint inhibitors","volume":"26","author":"Sch\u00f6nberger","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.21037\/tlcr-21-524","article-title":"The safety and efficacy of immunotherapy with anti-programmed cell death 1 monoclonal antibody for lung cancer complicated with mycobacterium tuberculosis infection","volume":"10","author":"Shi","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e88696","DOI":"10.7759\/cureus.88696","article-title":"Reactivation of latent varicella-zoster virus leading to meningitis in a patient with malignant pleural mesothelioma undergoing immune checkpoint inhibitor therapy: a case report","volume":"17","author":"Shionoya","year":"2025","journal-title":"Cureus"},{"key":"B24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1086\/589747","article-title":"The management of encephalitis: clinical practice guidelines by the infectious diseases society of america","volume":"47","author":"Tunkel","year":"2008","journal-title":"Clin. Infect. Dis."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1937378\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:51:48Z","timestamp":1791348708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1937378\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":24,"alternative-id":["10.3389\/fphar.2026.1937378"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1937378","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"article-number":"1937378"}}